3:49VIDEO56 mins agoHackensack Meridian Health CEO on COVID-19 vaccination processBob Garrett, Hackensack Meridian Health CEO, speaks on vaccination progress in New Jersey.
4:19VIDEO3 hours agoDr. Marc Siegel: J&J vaccine decreases hospitalization, death by 100 percentFox News medical contributor Dr. Marc Siegel with insight on the single-dose Johnson & Johnson coronavirus vaccine.
4:03VIDEO1 day agoAmerican mask manufacturer DemeTECH having trouble selling N95 masksDemeTECH Vice President Luis Arguello Jr. discusses why his company is having difficulty selling its masks.
Coronavirus3 days agoCoronavirus antibodies offer protection from reinfection, study suggestsA study published Wednesday in the journal JAMA Internal Medicine suggests that those who have COVID-19 antibodies have a significantly lower risk of reinfection compared to those who do not have them.
Coronavirus4 days agoPfizer COVID-19 vaccine 94% effective in real-world conditions: studyA coronavirus vaccine developed by Pfizer and BioNTech showed to drop symptomatic COVID-19 by 94%, per new research out of Israel. The peer-reviewed results offer a first look at effectiveness in real-world conditions, and showed consistency with high 95% vaccine efficacy reported during clinical trials.
4:33VIDEO4 days agoNew coronavirus variant discovered in tri-state areaOfficials say new strand could be more resistant to COVID-19 vaccines. Reaction from Fox News medical contributor Dr. Janette Nesheiwat.
Coronavirus4 days agoCalifornia coronavirus variant may spread faster, inflict severe disease, early data suggestsEarly data suggests a coronavirus variant first detected in California may be more transmissible, possibly cause more severe disease, and could have an impact on vaccine efficacy.
Coronavirus5 days agoCoronavirus less likely to infect glasses wearers, study suggestsGood news, glasses wearers: Your spectacles may offer you some extra protection from the novel coronavirus, according to the findings of a new study.
Coronavirus6 days agoAgony of post-COVID-19 loss of smellA year into the coronavirus pandemic, doctors and researchers are still striving to better understand and treat the accompanying epidemic of COVID-19-related anosmia — loss of smell — draining much of the joy of life from an increasing number of sensorially frustrated longer-term sufferers like Forgione.
Coronavirus6 days agoGSK, Sanofi start new COVID-19 vaccine study after setbackGlaxoSmithKline and Sanofi on Monday announced the start of a new Phase 2 trial involving their protein-based COVID-19 vaccine candidate after facing a setback in December.
